These cancer patient data support the notion that the NPM1/HIF‐1α interaction also occurs in solid tumors and it is highly involved in the response of cancer cells to the hypoxic tumor microenvironment, which in turn can facilitate tumor growth and resistance to therapy. This evidence concerns the gene HIF1A and cancer.